Equipment and process issues could lead to a lack of sterility.
SterRx is recalling about 240 lots of 12 different products. The recall is being made because of due equipment and process issues that could lead to a lack of sterility. To date, SterRx has not received reports of adverse events associated.
These lots were distributed between December 2020 and October 2021.
The products impacted include:
Those with questions should call (518) 324-7983 or email Recall@sterrx.com.
FDA and EMA Accepts Applications for New Nusinersen Regimen
January 23rd 2025An investigational higher dose of spinal muscular atrophy drug nusinersen gains attention as the FDA and European Medicines Agency (EMA) considerate it as an alternative than the current lower FDA-approved dosage.
Read More